Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer
1975 • 207 citations
Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors
1973 • 184 citations
Etoposide (VP-16-213)
1979 • 151 citations
Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival
1976 • 124 citations
Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer
1975 • 115 citations
Combination chemotherapy of carcinoma of the breast
1974 • 81 citations
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
1980 • 63 citations
The chemical therapy of breast cancer.
1974 • 60 citations
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy
1978 • 27 citations
Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
1979 • 14 citations
Chemo Immunotherapy of Advanced Breast Cancer With BCG
1977 • 8 citations
Cited By (0)
No citing papers found in database